4,6-Dichloro-2-Methylpyrimidine CAS 1780-26-3 Ịdị Ọcha ≥99.5% (GC) Ụlọ Ọrụ Na-ekpo ọkụ

Nkọwa dị mkpirikpi:

Aha ọgwụ: 4,6-Dichloro-2-Methylpyrimidine

Ọnọdụ: 1780-26-3

Ịdị ọcha: ≥99.5% (GC)

Ọdịdị: White ma ọ bụ Gbanyụọ-White Crystalline ntụ ntụ

Ogo dị elu, mmepụta azụmahịa

Ọkara nke Dasatinib / Moxonidine

E-Mail: alvin@ruifuchem.com

Zitere anyị email

Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) with high quality, commercial production. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com

Njirimara kemịkalụ:

Aha Chemical	4,6-Dichloro-2-Methylpyrimidine
Ụdị okwu	2-Methyl-4,6-Dichloropyrimidine;2,4-Dichloro-6-Methylpyrimidine
Nọmba CAS	1780-26-3
Nọmba CAT	RF-PI687
Ọnọdụ Ahịa	N'ọkwa, Mpụta Ihe ruru Tọn
Usoro ihe omimi	C5H4Cl2N2
Ibu molekụla	163.00
Ebe Na-agbaze	41.5 ~ 45.5 ℃ (ọkụ)
Solubility (Na-agbaze na)	Methanol
Ụdị	Ruifu Chemical

Nkọwapụta:

Ihe	Nkọwapụta
Ọdịdị	Ntụ ntụ kristal na-acha ọcha ma ọ bụ gbanyụọ
Ụzọ ịdị ọcha / nyocha	≥99.5% (GC)
Ọnwụ na ihicha	≤0.50%
Ihe fọdụrụ na mgbanye	≤0.20%
Otu adịghị ọcha	≤0.50%
Mgbakọta adịghị ọcha	≤0.50%
Nlele ọkọlọtọ	Standardkpụrụ ụlọ ọrụ
Ojiji	Ndị na-emepụta ọgwụ na etiti;Dasatinib/Moxonidine Intermediate

4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) Ụzọ Usoro

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Aluminom foil bag, 25kg / Cardboard Drum, ma ọ bụ dị ka ndị ahịa chọrọ

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri

Uru:

Ajụjụ:

Ngwa:

A na-eji 4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) mee ihe na njikọ nke etiti ọgwụ na API.Ngwaahịa Nkwadebe: Moxonidine (CAS: 75438-57-2);Dasatinib (CAS: 302962-49-8);Dasatinib Monohydrate (CAS: 863127-77-9);4-Chloro-2,6-Dimethylpyrimidine (CAS: 4472-45-1);4-Amino-6-Chloro-2-Methylpyrimidine (CAS: 1749-68-4).Moxonidine bụ ụdị ọgwụ mgbochi hypertensive ọhụrụ, nke a na-ejikarị na ọgwụgwọ ọbara mgbali elu dị mkpa.Tụnyere ọgwụ mgbochi hypertensive nke etiti na-eme agadi, Moxonidine na-ejikọta ya na imidazoline I1-receptor karịa na α2-receptor.Dasatinib bụ onye na-egbochi oncogenic kinase inhibitor, nke nwere ike igbochi mgbaàmà nke mmụba mkpụrụ ndụ kansa cancer, na May 2009, US Food and Drug Administration (FDA) kwadoro ire dasatinib, a na-eji ya eme ihe maka ọgwụgwọ ọrịa dị iche iche na-adịghị ala ala. myeloid leukemia (CML), gụnyere ọgwụgwọ nke ọrịa leukemia myeloid na-adịghị ala ala nke na-eguzogide ma ọ bụ na-anabataghị mmemme ọgwụgwọ gụnyere imatinib mesylate., Philadelphia chromosome-positive nnukwu lymphoblastic leukemia (Ph + ALL) na ọgwụgwọ nke ndị ọrịa nwere etuto siri ike.